HU-331 is a synthetic compound derived from the natural cannabinoid cannabidiol (CBD). It is not found naturally in cannabis plants but is a synthetic derivative with potential therapeutic properties. The compound is structurally related to CBD, with modifications to its molecular structure. It is a quinone derivative with a substituted hydroxyl group and a naphthyl ring system.

Pharmacologically, HU-331 has shown various potential therapeutic effects. It exhibits anti-cancer properties and has been studied for its potential in inhibiting the growth and proliferation of cancer cells. HU-331 has also demonstrated anti-inflammatory and neuroprotective effects, suggesting potential benefits in reducing inflammation and protecting nerve cells from damage.

HU-331 is not a natural cannabinoid but is derived from CBD. It interacts with the endocannabinoid system (ECS) and may modulate cannabinoid receptors to exert its pharmacological effects. However, it is essential to note that HU-331 is a synthetic compound and does not occur naturally in cannabis plants.

Cannabidiol quinone